Oncology & Cancer
Cause and potential treatment found for cancer drug's kidney toxicity
Scientists may have a way to make the powerful cancer drug cisplatin less toxic to the kidneys and more effective against some cancers.
Jun 2, 2011
0
0
Page 8 - News tagged with cancer agent
Oncology & Cancer
Peptides for fighting ovarian cancer developed
A team of German and Italian EU-funded scientists has designed peptides that can target the protein-protein interface of an enzyme that plays a key part in the DNA synthesis crucial for cancer growth.
Aug 8, 2011
0
0
Oncology & Cancer
Targeted therapeutics for colon cancer to be presented at AACR meeting
Anurag Singh, PhD, assistant professor in the Department of Pharmacology and Experimental Therapeutics at Boston University School of Medicine has been invited to present his recent work on targeted therapeutics for colon ...
Apr 4, 2012
0
0
Oncology & Cancer
Abcc10 may be effective in extending the effectiveness of anticancer drugs
Today's anticancer drugs often work wonders against malignancies, but sometimes tumors become resistant to the effects of such drugs, and treatment fails. Medical researchers would like to find ways of counteracting such ...
May 16, 2011
0
0
Medical research
Exploring a novel treatment for K-Ras mutant pancreatic tumors
Often undetected until it has progressed to an advanced stage, pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer. The K-Ras mutant pancreatic cancer is one of the most common types. At present, there are no effective ...
Jun 6, 2022
0
1
Other
AMP opposes exclusive licensing of NIH proteomics patent
The Association for Molecular Pathology (AMP) opposed the National Institutes of Health (NIH) proposal to exclusively license the subject matter of a cancer-related proteonomics patent application filed by the Agency. AMP's ...
Nov 22, 2011
1
0
Oncology & Cancer
Experimental 'stapled peptide' drug blocks key cancer molecule
(Medical Xpress)—US scientists have developed an artificial molecule called a 'stapled peptide' that can shut down the cancer-fuelling effects of a molecule called Wnt.
Aug 24, 2012
0
0
Oncology & Cancer
Possible new pathway can overcome glioblastoma resistance
Glioblastoma, a lethal brain cancer, is one of the most resistant to available therapies and patients typically live approximately 15 months.
Jan 24, 2012
0
0
Medical research
Newly identified DNA repair defect linked to increased risk of leukemia relapse
A newly identified defect in a DNA repair system might leave some young leukemia patients less likely to benefit from a key chemotherapy drug, possibly putting them at greater risk of relapse. The problem was identified in ...
Sep 26, 2011
1
0
Oncology & Cancer
New type of drug leads to hope against resistant ovarian cancer
Scientists at USC have discovered a new type of drug for the treatment of ovarian cancer that works in a way that should not only decrease the number of doses that patients need to take, but also may make it effective for ...
Oct 3, 2012
0
0
